Restricted accessResearch articleFirst published online March, 2026

Patient voice: The label given to my MS disease course matters to me—Yes

Volume 32, Issue 3https://doi.org/10.1177/13524585251396262

Abstract

Get full access to this article

View all access options for this article.

References

1.

Lublin

FD

Reingold

SC.

Defining the clinical course of multiple sclerosis: Results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996; 46: 907–911.